SPOTLIGHT -
Drugs, therapy help OCD patients
New drug treatments are offering hope to patients who suffer from autism, compulsive buying and hypochondria, according to one expert in the field.
New breast cancer Web site launched
Patients and professionals who want more information on breast cancer have a new resource on the Internet's World Wide Web.
New guidelines out on drug purchasing
Two researchers have published new guidelines for managed care systems to evaluate drug products.
Six weeks to a copromotion
Not long after the Olympic athletes took their medals home from Atlanta last summer, one area pharmaceutical company won another kind of competition.
Reps' 1997 resolutions
Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.
Kessler steps down from the FDA
FDA Commissioner David Kessler, M.D., is leaving after six years at the agency
Distributor, manufacturer merge to form BBI Healthcare
One of the largest drug wholesalers in the United States agreed to merge with a major drug maker known for its generic products.
What experts predict this year
Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.
Alzheimer's expert is optimistic
More than 4 million people suffer from Alzheimer's disease, according to the Chicago-based Alzheimer's Association. The progressive dementing illness gradually robs its victims of mind, independence and identity.
Guidelines out on psychiatric disorders
Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.
Anticancer vaccine approved
In a significant victory against cancer, FDA has approved the first vaccine developed to prevent cervical cancer,
Supreme Court: Research Use of Patented Compounds OK
We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.
